{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:24Z","timestamp":1792794564676,"version":"4.5.0"},"reference-count":40,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,2,19]]},"DOI":"10.1167\/iovs.67.2.37","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:00:44Z","timestamp":1771509644000},"page":"37","source":"Crossref","is-referenced-by-count":3,"title":["In-Depth Analysis of the Intravitreal Biocompatibility of Polyethylene Glycol of Different Molecular Weight in an In Vivo Porcine Model"],"prefix":"10.1167","volume":"67","author":[{"given":"Maximilian","family":"Hammer","sequence":"first","affiliation":[{"name":"University Clinic Heidelberg, Department of Ophthalmology, Heidelberg, Germany"},{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Geisweid","sequence":"additional","affiliation":[{"name":"University Clinic Heidelberg, Department of Ophthalmology, Heidelberg, Germany"},{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Junker","sequence":"additional","affiliation":[{"name":"University Clinic Heidelberg, Department of Ophthalmology, Heidelberg, Germany"},{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Wohlfart","sequence":"additional","affiliation":[{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"},{"name":"Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Skrzypczyk","sequence":"additional","affiliation":[{"name":"University Clinic Heidelberg, Department of Ophthalmology, Heidelberg, Germany"},{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan Calder","family":"Ackermann","sequence":"additional","affiliation":[{"name":"University Clinic Heidelberg, Department of Ophthalmology, Heidelberg, Germany"},{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Herth","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Molecular Biotechnology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Studier-Fischer","sequence":"additional","affiliation":[{"name":"Department of Urology and Urological Surgery, University Medical Center Mannheim, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd U.","family":"Auffarth","sequence":"additional","affiliation":[{"name":"University Clinic Heidelberg, Department of Ophthalmology, Heidelberg, Germany"},{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A.","family":"Augustin","sequence":"additional","affiliation":[{"name":"University Clinic Heidelberg, Department of Ophthalmology, Heidelberg, Germany"},{"name":"David J. Apple Laboratory for Vision Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Uhl","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Molecular Biotechnology, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"4","key":"bib1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","article-title":"Update on intravitreal injections: euretina expert consensus recommendations","volume":"239","author":"Grzybowski","year":"2018","journal-title":"Ophthalmologica"},{"issue":"1","key":"bib2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40123-020-00230-4","article-title":"Intravitreal injections with vascular endothelial growth factor inhibitors: a practical approach","volume":"9","author":"Petri","year":"2020","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"bib3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molimm.2014.06.032","article-title":"Genetic variants in the complement system predisposing to age-related macular degeneration: a review","volume":"61","author":"Schramm","year":"2014","journal-title":"Mol Immunol"},{"issue":"5","key":"bib4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","article-title":"The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target","volume":"37","author":"Boyer","year":"2017","journal-title":"Retina"},{"issue":"10411","key":"bib5","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"bib6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaophthalmol.2024.1269","article-title":"Pegcetacoplan treatment and consensus features of geographic atrophy over 24 months","volume":"142","author":"Fu","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"bib8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/tvst.7.4.21","article-title":"A controlled release system for long-acting intravitreal delivery of small molecules","volume":"7","author":"Machinaga","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"bib9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"bib10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","article-title":"Chemistry for peptide and protein PEGylation","volume":"54","author":"Roberts","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/24741264231220224","article-title":"Retinal vasculitis after intravitreal pegcetacoplan: report from the ASRS Research and Safety in Therapeutics (ReST) Committee","volume":"8","author":"Witkin","year":"2024","journal-title":"J Vitreoretin Dis"},{"issue":"18","key":"bib12","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1074\/jbc.M110.204701","article-title":"Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization","volume":"286","author":"Lyzogubov","year":"2011","journal-title":"J Biol Chem"},{"key":"bib13","first-page":"194","article-title":"Reliability and reproducibility of a rodent model of choroidal neovascularization based on the subretinal injection of polyethylene glycol","volume":"25","author":"Fernandez-Bueno","year":"2019","journal-title":"Mol Vis"},{"issue":"2","key":"bib14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/jop.2015.0069","article-title":"Retinal toxicity of intravitreal polyethylene glycol 400","volume":"32","author":"Patel","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib15","article-title":"Intraocular inflammation, safety events, and outcomes after intravitreal injection of ranibizumab, aflibercept, brolucizumab, abicipar pegol, and faricimab for nAMD [published online ahead of print April 21, 2025]","author":"Stevanovic","journal-title":"J Vitreoretin Dis"},{"issue":"2","key":"bib16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000310085","article-title":"Effect of ethylene glycol on rabbit retinas","volume":"200","author":"Rossa","year":"1990","journal-title":"Ophthalmologica"},{"issue":"8","key":"bib17","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1167\/iovs.14-15349","article-title":"In vivo and in vitro feasibility studies of intraocular use of polyethylene glycol-based synthetic sealant to close retinal breaks in porcine and rabbit eyes","volume":"56","author":"Hoshi","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"bib18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.exer.2014.07.021","article-title":"Polyethylene glycol induced mouse model of retinal degeneration","volume":"127","author":"Lyzogubov","year":"2014","journal-title":"Exp Eye Res."},{"issue":"3","key":"bib19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/08982109909018655","article-title":"Effect of repeated intravenous administration on the circulation kinetics of poly(ethyleneglycol)-liposomes in rats","volume":"9","author":"Oussoren","year":"1999","journal-title":"J Liposome Res"},{"issue":"3","key":"bib20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"bib21","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/ar4500","article-title":"Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"bib22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J Control Release"},{"issue":"1","key":"bib23","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar1861","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","volume":"8","author":"Ganson","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"bib24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","article-title":"Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics","volume":"19","author":"Verhoef","year":"2014","journal-title":"Drug Discov Today"},{"issue":"23","key":"bib25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1200\/JCO.18.02439","article-title":"Antibodies predict pegaspargase allergic reactions and failure of rechallenge","volume":"37","author":"Liu","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"bib26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol Immunol"},{"issue":"9","key":"bib27","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann Oncol."},{"issue":"8","key":"bib28","doi-asserted-by":"publisher","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","article-title":"Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions","volume":"13","author":"Kozma","year":"2019","journal-title":"ACS Nano"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1182\/blood-2021-148069","article-title":"The pharmacokinetics, pharmacodynamics, and safety of intravenous pegcetacoplan treatment in healthy subjects","volume":"138","author":"Grossi","year":"2021","journal-title":"Blood"},{"issue":"3","key":"bib30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ophtha.2015.10.056","article-title":"Risk of retinal neovascularization in cases of uveitis","volume":"123","author":"Patel","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"bib31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/ijms23010386","article-title":"The role of inflammation in retinal neurodegeneration and degenerative diseases","volume":"23","author":"Kaur","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"bib32","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","article-title":"Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein","volume":"12","author":"Mima","year":"2015","journal-title":"Mol Pharm"},{"issue":"1","key":"bib33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"bib34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/pharmaceutics12010015","article-title":"Both IgM and IgG antibodies against polyethylene glycol can alter the biological activity of methoxy polyethylene glycol-epoetin beta in mice","volume":"12","author":"Chang","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"bib35","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/cea.12760","article-title":"Immediate-type hypersensitivity to polyethylene glycols: a review","volume":"46","author":"Wenande","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.curtheres.2024.100742","article-title":"Immunogenicity and potential for intraocular inflammation of intravitreal anti-VEGF drugs","volume":"100","author":"Kim","year":"2024","journal-title":"Curr Ther Res Clin Exp"},{"issue":"1","key":"bib37","first-page":"41","article-title":"A prediction model for the intraocular pharmacokinetics of intravitreally injected drugs based on molecular physicochemical properties","volume":"63","author":"Kim Hyeong","year":"2019","journal-title":"Ophthalmic Res"},{"issue":"4","key":"bib38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ajo.2014.05.037","article-title":"Treatment of exudative age-related macular degeneration with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I\/II study","volume":"158","author":"Souied","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"27","key":"bib39","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"bib40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.2.37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:18Z","timestamp":1791927138000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.2.37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.2.37","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}